Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Anthony Fauci. Photo: Stefani Reynolds-Pool/Getty Images

The FDA and CDC will likely allow some flexibility for recipients of the Johnson & Johnson COVID-19 to mix and match vaccine boosters, NIAID director Anthony Fauci told ABC News' '"This Week" on Sunday.

Yes, but: The FDA still needs to look at all the data before making a formal authorization, he said.

  • "What likely will happen is that both FDA in their authorization and the CDC will likely give a degree of flexibility based on the individual situations," Fauci said.

Driving the news: NIH data presented on Friday to a key FDA advisory committee showed people who received a shot of J&J's vaccine have a stronger neutralizing antibody response if they receive an mRNA shot instead of a second J&J one.

  • While the committee voted to endorse J&J boosters, they did not yet vote on the "mix-and-match strategy."

What they're saying: "The dogma has always been for other vaccines, you always want to boost with what you’ve primed with. But in this instance, that seems to be different," said board member Archana Chatterjee, who is also dean of the Chicago Medical School.

  • "I'm sold already," said Mark Sawyer, an infectious disease specialist at Rady Children's Hospital. "We need flexibility and improved access."

But, but, but: Advisory board members also identified several data points they're still looking for.

  • For instance, they said, they wanted more data on the longevity of the antibody response.
  • They said they also need to understand what happens to cellular immunity, not just the antibody response, when mixing vaccines.
  • They'd also want to see data on what happens in children when mixing vaccines, as well as better data on underrepresented populations.

The bottom line: While some would like more data, "it does seem there is some consensus this is an important option for people to have," said the FDA's Center for Biologics Evaluation and Research director Peter Marks.

Go deeper: COVID-19 booster shots overtake first doses in the U.S.

Go deeper

Dec 6, 2021 - Health

Cruise ship COVID outbreak: Louisiana officials find "probable" Omicron case

The Norwegian Breakaway cruise ship. Photo: Gerard Bottino/SOPA Images/LightRocket via Getty Images

Louisiana health authorities said a suspected Omicron case was one of 17 confirmed COVID-19 infections among the passengers and crew of a Norwegian Cruise Lines ship that returned to New Orleans Sunday.

Driving the news: The Norwegian Breakaway departed New Orleans on Nov. 28 with more than 3,200 people on board, before making stops in Belize, Honduras and Mexico, according to a Louisiana Department of Health statement.

Dec 6, 2021 - Health

CDC raises travel advisories for France, Portugal to highest level amid COVID surge

Angus Mordant/Bloomberg via Getty Images

The Centers for Disease Control and Prevention raised COVID-19 travel advisories to their highest levels for a number of countries on Monday, including France and Portugal.

Why it matters: The detection of the new Omicron variant last month has spurred fears of a new wave of virus infections.

Gov. Hochul will order some NY hospitals to halt elective surgeries

New York State Gov. Kathy Hochul COVID-19 addresses rising cases in the state and the new variant Omicron at a press conference in November. Photo: Lev Radin/Pacific Press/LightRocket via Getty Images

New York Gov. Kathy Hochul announced on Monday that some state hospitals will be ordered to halt certain elective surgeries in an effort to combat a recent COVID-19 surge, Hochul said at a press conference.

Why it matters: New York has struggled with hospital capacity throughout the pandemic and postponed nonessential procedures before.